Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting

To estimate real-world healthcare costs, resource utilization, and treatment patterns among metastatic melanoma (MM) patients who received a therapy recommended in current treatment guidelines during 2011 and 2012, following approval in the US of novel therapies (ipilimumab and vemurafenib). Adminis...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Current medical research and opinion Ročník 31; číslo 8; s. 1561 - 1572
Hlavní autori:	Toy, Edmond L., Vekeman, Francis, Lewis, Michael C., Oglesby, Alan K., Duh, Mei Sheng
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Informa Healthcare 03.08.2015
Predmet:	Adult Aged Antibodies, Monoclonal - therapeutic use Cohort Studies Female Health Care Costs Health Resources - utilization Healthcare costs Humans Ipilimumab Male Melanoma - secondary Melanoma - therapy Metastatic melanoma Middle Aged Resource utilization Retrospective Studies Treatment patterns Healthcare costs Metastatic melanoma Resource utilization Treatment patterns
ISSN:	0300-7995, 1473-4877
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!